Corebridge Financial Inc. reduced its stake in Inari Medical, Inc. (NASDAQ:NARI – Free Report) by 7.2% during the fourth ...

Several spine and orthopedic companies have made progress with acquisitions in the first quarter of 2025. 1. Stryker has ...

Shares of Inari Medical, Inc. (NASDAQ:NARI – Get Free Report) have been given an average rating of “Hold” by the fourteen brokerages that are currently covering the stock, MarketBeat reports. Twelve ...

Equally importantly, the company continues to gain share from its chief rival Inari – I would estimate ... large part to a strong position in pulmonary embolism (likely around 75% share, though ...

Artix builds on Inari’s portfolio of nitinol-enabled devices and systems like the FlowTriever for pulmonary embolism (PE), ClotTriever for deep vein thrombosis (DVT) and the LimFlow system for ...

A new study investigating D-dimer testing in patients who are at higher risk of pulmonary embolism (PE) has been published in the February issue of Academic Emergency Medicine (AEM), the peer-reviewed ...

Pulmonary embolism is a common cause of cardiovascular-associated morbidity and mortality. Although pulmonary embolism affects individuals from all demographics, the incidence of pulmonary embolism is ...

A 33-year-old “perfectly healthy” woman is issuing a warning to travelers after she nearly died from a massive blood clot in ...

In the 1990s, fewer than 350 people spoke Inari Sámi. Today, experts say about 500 people speak the near-extinct language, and the movement to learn it is growing. Ingrid Gaup braids dried "shoe ...

PORTAGE, Mich., March 6, 2025 /PRNewswire/ -- Inari Medical, now part of Stryker (NYSE: SYK), a global leader in medical technologies, announced the launch of its Artix Thrombectomy System.